NAUTNautilus Biotechnolgy, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19001
Ticker: NAUT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-06-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: NAUT

Detail

Enriched 2026-08-14 20:47

Market cap: $114,491,524.13
Shares outstanding (class): 127,255,223
Shares outstanding (weighted): 127,255,223
SIC: 3826 LABORATORY ANALYTICAL INSTRUMENTS
Employees: 130
Location: SEATTLE, WA
Homepage: https://www.nautilus.bio
Description: Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Market cap and share counts drift.

Funds holding this security

10 funds · 10 positions · $10.60M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$7.49M	0.00%	1,930,610 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.05M	0.00%	527,719 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$504.4K	0.41%	130,000 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$196.0K	0.00%	50,505 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$142.6K	0.00%	36,763 NS	FIGI
SMALL CAP EQUITY FUND GuideStone Funds	—	$105.1K	0.01%	27,094 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$65.3K	0.00%	16,822 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$21.6K	0.00%	5,558 NS	FIGI
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$19.9K	0.00%	5,121 NS	FIGI
Diversified Equity Master Portfolio Master Investment Portfolio	—	$11.3K	0.00%	2,915 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERNAUT
FIGI_COMPOSITEBBG00W7G4M12
FIGI_SHARE_CLASSBBG00W7G4MV9
CIK0001808805
ISINUS63909J1088
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Life Sciences Tools
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Nautilus Biotechnology develops protein analysis instruments, fitting the life science tools industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.